Pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors

Talazoparib, a poly(ADP-ribose) polymerase inhibitor, has demonstrated efficacy in the treatment of advanced breast and prostate cancers in Western populations. This open-label, phase 1 study investigated the pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yang, Cheng, Ying, Wu, Chunjiao, Ye, Hui, Chen, Naihan, Zhang, Fan, Wei, Hua, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290043/
https://www.ncbi.nlm.nih.gov/pubmed/37171721
http://dx.doi.org/10.1007/s10637-023-01351-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290043/
https://www.ncbi.nlm.nih.gov/pubmed/37171721
http://dx.doi.org/10.1007/s10637-023-01351-w

Ejemplares similares